|
|
News
July 23, 2009
PharmaVize establishes partnership with Xedev.Xedev (www.xedev.com)
is a spin-out company of ProCepT, a Belgian manufacturer of small
scale processing equipment. Xedev offers process screening and
feasibility services using ProCepT’s technology for Agglomeration,
Coating and Drying, such as spray drying, fluid bed, high shear
granulation, extrusion, spheronisation, coating, vacuum and
microwave drying.PharmaVize (www.pharmavize.com)
is a GMP-compliant contract research company. The company offers
formulation screening and development services and is producing
pre-clinical and GMP clinical supply materials.
By joining forces and offering an integrated service level, Xedev
and PharmaVize aim at accelerating the development of early phase
drug substances and drug products.
“By combining the process know-how of Xedev and the formulation
know-how of PharmaVize, we create valuable synergies”, says Lieven
Van Vooren, CSO at PharmaVize. “Our team takes on early development
challenges such as drug stability, solubility and bio-availability”.
“We offer process screening and feasibility studies”, adds Filip
Van der Gucht, Business Dev Director of Xedev. “We select the right
process technology and then optimize the manufacturing process. Upon
request of our customer, we can transfer the process to the GMP
infrastructure of PharmaVize and produce clinical supply materials
for early phase studies. Our integrated approach is shortening the
product development time significantly”. |